BillionToOne Inc/$BLLN
1D1W1MYTD1Y5YMAX
About BillionToOne Inc
BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.
- Ticker
- $BLLN
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 713
- Headquarters
- Menlo Park, United States
- Website
- www.billiontoone.com
BillionToOne Inc Metrics
BasicAdvanced
$4.5B
123.57
$0.77
-
-
Price and volume
Market cap
$4.5B
52-week high
$150.44
52-week low
$61.96
Average daily volume
752K
Financial strength
Current ratio
11.689
Quick ratio
11.189
Long term debt to equity
25.552
Total debt to equity
26.811
Interest coverage (TTM)
1,056.15%
Profitability
EBITDA (TTM)
50.239
Gross margin (TTM)
71.27%
Net profit margin (TTM)
8.35%
Operating margin (TTM)
10.90%
Effective tax rate (TTM)
0.51%
Revenue per employee (TTM)
$560,000
Management effectiveness
Return on assets (TTM)
5.19%
Return on equity (TTM)
10.68%
Valuation
Price to earnings (TTM)
123.573
Price to revenue (TTM)
8.079
Price to book
8.29
Price to tangible book (TTM)
8.29
Price to free cash flow (TTM)
96.901
Free cash flow yield (TTM)
1.03%
Free cash flow per share (TTM)
0.981
Growth
Revenue change (TTM)
90.12%
Earnings per share change (TTM)
-125.73%
What the Analysts think about BillionToOne Inc
Analyst ratings (Buy, Hold, Sell) for BillionToOne Inc stock.
BillionToOne Inc Financial Performance
Revenues and expenses
BillionToOne Inc Earnings Performance
Company profitability
BillionToOne Inc News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.